The pathogenic mutations in genes such as MUTYH, FANCD2, NBN, PALB2, and BRCA1 are associated with hereditary breast and ovarian cancer syndrome, an autosomal dominant disorder typically manifesting around age 30 and above [76]. Here, PALB2 is linked to hereditary breast ovarian cancer syndrome.